Dissection of the Transversus Abdominis muscle for whole-mount neuromuscular junction analysis

Journal of Visualized Experiments

Volumn , Issue 83, 2014, Pages

  Murray, Lyndsay ^a   Gillingwater, Thomas H ^b   Kothary, Rashmi ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Dissection; Immunofluorescence; Issue 83; Mouse; Neuromuscular junction; Neuroscience; NMJ; Transversus Abdominis

Indexed keywords

ABDOMINAL WALL MUSCULATURE; ANIMAL; ARTICLE; DISSECTION; FLUORESCENT ANTIBODY TECHNIQUE; HISTOLOGY; INJURY; METHODOLOGY; MOUSE; NEUROMUSCULAR SYNAPSE;

ABDOMINAL MUSCLES; ANIMALS; DISSECTION; FLUORESCENT ANTIBODY TECHNIQUE; MICE; NEUROMUSCULAR JUNCTION;

EID: 84903369048     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/51162     Document Type: Article

References (20)

1. Sanes, J. R. & Lichtman, J. W. Development of the vertebrate neuromuscular junction. Annu. Rev. Neurosci. 22, 389-442, doi:10.1146/annurev.neuro.22.1.389 (1999).
2. Dupuis, L. & Loeffler, J. P. Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models. Curr. Opin. Pharmacol.9, 341-346, doi:10.1016/j.coph.2009.03.007 (2009).
3. Murray, L. M., Talbot, K. & Gillingwater, T. H. Review: neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy. Neuropathol. Appl. Neurobiol. 36, 133-156, doi:10.1111/j.1365-2990.2010.01061.x (2010).
4. Murray, L. M. et al. Selective vulnerability of motor neurons and dissociation of pre-and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Hum. Mol. Genet. 17, 949-962, doi:10.1093/hmg/ddm367 (2008).
5. Kariya, S. et al. Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy. Hum. Mol. Genet.17, 2552-2569, doi:10.1093/hmg/ddn156 (2008).
6. Iguchi, Y. et al. Loss of TDP-43 causes age-dependent progressive motor neuron degeneration. Brain. 136, 1371-1382, doi:10.1093/brain/awt029 (2013).
7. Martinez-Hernandez, R. et al. Synaptic defects in type I spinal muscular atrophy in human development. J. Pathol. 229, 49-61, doi:10.1002/path.4080 (2013).
8. Fischer, L. R., Li, Y., Asress, S. A., Jones, D. P. & Glass, J. D. Absence of SOD1 leads to oxidative stress in peripheral nerve and causes a progressive distal motor axonopathy. Exp. Neurol. 233, 163-171, doi:10.1016/j.expneurol.2011.09.020 (2012).
9. Cifuentes-Diaz, C. et al. Neurofilament accumulation at the motor endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model. Hum. Mol. Genet. 11, 1439-1447 (2002).
10. Fischer, L. R. et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 185, 232-240 (2004).
11. Diers, A., Kaczinski, M., Grohmann, K., Hubner, C. & Stoltenburg-Didinger, G. The ultrastructure of peripheral nerve, motor end-plate and skeletal muscle in patients suffering from spinal muscular atrophy with respiratory distress type 1 (SMARD1). Acta Neuropathol. 110, 289-297, doi:10.1007/s00401-005-1056-y (2005).
12. Ang, E. T. et al. Motor axonal sprouting and neuromuscular junction loss in an animal model of Charcot-Marie-Tooth disease. J. Neuropathol. Exp. Neurol.69, 281-293, doi:10.1097/NEN.0b013e3181d1e60f (2010).
13. Simon, C. M., Jablonka, S., Ruiz, R., Tabares, L. & Sendtner, M. Ciliary neurotrophic factor-induced sprouting preserves motor function in a mouse model of mild spinal muscular atrophy. Hum. Mol. Genet. 19, 973-986, doi:10.1093/hmg/ddp562 (2010).
14. Murray, L. M., Gillingwater, T. H. & Parson, S. H. Using mouse cranial muscles to investigate neuromuscular pathology in vivo. Neuromuscul. Disord. 20, 740-743, doi:10.1016/j.nmd.2010.06.013 (2010).
15. Brill, M. S., Marinkovic, P. & Misgeld, T. Sequential photo-bleaching to delineate single Schwann cells at the neuromuscular junction. J. Vis. Exp. e4460, doi:10.3791/4460 (2013).
16. Murray, L. M., Thomson, D., Conklin, A., Wishart, T. M. & Gillingwater, T. H. Loss of translation elongation factor (eEF1A2) expression in vivodifferentiates between Wallerian degeneration and dying-back neuronal pathology. J. Anat. 213, 633-645, doi:10.1111/j.1469-7580.2008.01007.x (2008).
17. Bowerman, M., Murray, L. M., Beauvais, A., Pinheiro, B. & Kothary, R. A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology. Neuromuscul. Disord. 22, 263-276, doi:10.1016/j.nmd.2011.09.007 (2012).
18. Comley, L. H. et al. ApoE isoform-specific regulation of regeneration in the peripheral nervous system. Hum. Mol. Genet. 20, 2406-2421, doi:10.1093/hmg/ddr147 (2011).
19. Wright, M., Kim, A., Son, Y. Subcutaneous administration of muscarinic antagonists and triple-immunostaining of the levator auris longus muscle in mice. J. Vis. Exp. (55), e3124, doi:10.3791/3124 (2011).
20. Ling, K. K., Gibbs, R. M., Feng, Z. & Ko, C. P. Severe neuromuscular denervation of clinically relevant muscles in a mouse model of spinal muscular atrophy. Hum. Mol. Genet. 21, 185-195, doi:10.1093/hmg/ddr453 (2012).